Application of nanosized Fe3O4 in anticancer drug carriers with target-orientation and sustained-release properties.
Biomed Mater
; 2(2): 132-4, 2007 Jun.
Article
em En
| MEDLINE
| ID: mdl-18458446
ABSTRACT
The purpose of this study was to prepare human serum albumin (HSA) microspheres with Fe(3)O(4) magnetic nanoparticles for tumor target therapy. Fe(3)O(4) was obtained by liquid-phase coprecipitation; HSA-coated magnetic particles were attained by solidification at high temperature. The result was that nanosized Fe(3)O(4) is a cubic crystal by XRD and the average size is 18.7 nm; the average size of HSA-coated magnetic particles is 341 nm. Fe(3)O(4) magnetic nanoparticles coated with HSA can be used for targeted-drug carriers with target-orientation and sustained-release properties.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Portadores de Fármacos
/
Compostos Ferrosos
/
Preparações de Ação Retardada
/
Nanoestruturas
/
Magnetismo
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article